Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Physician
Patient
Health Care Practitioner
Pharma / Biotech Industry
Other
Topics:
Head and Neck Cancers
•
Radiation Oncology
When using hyperfractionation with a BID regimen, what are typical dose constraints for the head and neck?
Answer from: Radiation Oncologist at Academic Institution
Similar to 2 Gy once daily with a little more wiggle room
Sign in or Register to read more
17721
Related Questions
Are any centers routinely using 55 Gy in 20 fractions with chemotherapy for definitive treatment of head and neck cancer following presentation of the HYPNO study?
Would you consider 50 Gy in 20 fractions for a primary head and neck malignancy in an elderly patient with poor KPS?
How would you best manage C-spine osteoradionecrosis?
In what cases of T3N0 glottic SCC, would you omit chemotherapy and offer radiation alone?
How would you approach SCC of unknown primary, p16-, EBV-, metastatic to a large 5.5 cm level 2 neck node, if you suspect a cutaneous origin after clinical workup?
Would you recommend lymph node biopsy in a patient with SCC of the right ventral tongue (~1 cm) post excision with close margins and no noted adenopathy on imaging?
What is your approach to managing asymptomatic ORN of the mandible?
How would you approach patients with high risk mucoepidermoid carcinoma (high grade) of the parotid gland for optimal adjuvant treatment?
Do you recommend radioactive iodine for Hürthle Cell thyroid carcinoma?
What are your top takeaways in Head & Neck Cancers from ASTRO 2024?